Navigation Links
New Colorectal Cancer Screening Coverage to Drive US Gastrointestinal Endoscopy Device Market to Almost $2.2 Billion by 2014
Date:8/19/2010

WALTHAM, Mass., Aug. 19 /PRNewswire/ -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, new coverage instituted under the Patient Protection and Affordable Care Act of 2010 will remove the financial disincentives associated with colorectal cancer screening for a large segment of the US population. As a result of these changes in reimbursement, a growing number of colorectal cancer screening procedures will be performed through 2014, driving sales of many gastrointestinal endoscopy devices, including videoscopes and biopsy forceps.

Under the health care act, all new health insurance policies must cover preventative exams, including colonoscopies, without charging out-of-pocket fees such as copayments or deductibles. All Medicare patients will therefore have colorectal cancer screening colonoscopies fully covered as of January 1, 2011. This expanded coverage of colorectal cancer screening procedures will increase the number of colonoscopies performed over the next five years. Sales of devices used in the procedures, such as colonoscopes and biopsy forceps, will also rise to meet this growing demand for colorectal cancer screening. Although colonoscopy volumes dipped in 2009 during the recession, they are climbing again and will continue to rise as increased medical insurance coverage encourages more Americans to undergo screening.

"At the height of the economic downturn, many Americans declined to undergo colorectal cancer screening because they lost insurance coverage for it or they felt that paying for a diagnostic procedure when they did not have any symptoms was not a priority for them in economically uncertain times," said Sara Scharf, Ph D, Analyst at MRG. "As this new coverage is put in place, patients will increasingly get screened for colorectal cancer."

MRG's new report, US Markets for Gastrointestinal Endoscopy Devices 2010, now includes more segments, detailed com
'/>"/>

SOURCE Millennium Research Group
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Poniard Pharmaceuticals Announces Phase 2 Trial of Picoplatin in Metastatic Colorectal Cancer Meets Primary Endpoint and Study Objectives
2. For Treatment of Metastatic Colorectal Cancer, Avastin Will Face Increasing Competition From Erbitux in Europe, Most Notably in Spain
3. Poniard Pharmaceuticals Announces Updated Positive Clinical Data from Phase 2 Trial of Picoplatin in Colorectal Cancer and New Phase 1 Cardiac Safety Trial Results
4. Amgen Announces Overall Survival Results for Vectibix(R) in First-Line Metastatic Colorectal Cancer
5. Vectibix(R) in Combination With Chemotherapy Significantly Improves Progression-Free Survival in First-Line Metastatic Colorectal Cancer
6. Vectibix(R) in Combination With Chemotherapy Significantly Improves Progression-Free Survival in Second-Line Metastatic Colorectal Cancer
7. Vectibix(R) Significantly Improved Progression-Free Survival in Second-Line Treatment of KRAS Wild-Type Metastatic Colorectal Cancer
8. Vectibix(R) in Combination With Chemotherapy Significantly Improved Progression-Free Survival in First-Line Metastatic Colorectal Cancer
9. ARUP Laboratories Applauds FDAs Decision on the Value of KRAS-Mutation Testing in Colorectal Cancer
10. Poniard Pharmaceuticals Announces Progression-Free Survival Data From Phase 2 Clinical Trial of Picoplatin in Metastatic Colorectal Cancer
11. Clinical Genomics Continues Progress in Developing Biomarker Portfolio for Colorectal Cancer Testing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... , May 24, 2013 China Biologic ... a leading fully integrated plasma-based biopharmaceutical company in ... has recently learned from a public announcement issued by ... public company listed on Shenzhen Stock Exchange, that on ... ("Ms. Chan"), one of the shareholders of ...
(Date:5/24/2013)... , May 24, 2013 In accordance with ... and Rule 14e-1 of the United States Exchange Act, Echo ... original offer for Elan Corporation (NYSE: ELN). Background ... ("Royalty Pharma") made an offer for the entire of the ... plc ("Elan") (the "Original Offer").  On 20 ...
(Date:5/24/2013)... LONDON , May 24, 2013 ... non-invasive administration for systemic delivery of therapeutic agents has ... the inhalation drug delivery showing significant promise. The crucial ... of a delivery device play a major role in ... been made in the development of new formulation techniques ...
Breaking Medicine Technology:China Biologic Comments on the Proposed Shanghai RAAS Transaction 2China Biologic Comments on the Proposed Shanghai RAAS Transaction 3China Biologic Comments on the Proposed Shanghai RAAS Transaction 4Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 2Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 3Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 4Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 5Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 6Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 7Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 8Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 9Inhalaltion Drug Delivery: 11-12 September - Berlin, Germany 2
(Date:5/24/2013)... 2013 The Dictation Source recently added ... clients. As a result of its National marketing efforts, ... 20 states around the nation. , Since 1991, The ... to the healthcare industry . Dictation Source is owned ... years of clinical work experience to provide the solutions ...
(Date:5/24/2013)... May 24, 2013 Based in ... a leading nationwide sales, installation and service provider ... and commercial applications. The company’s core products include ... lifts for mobility devices, pool lifts, turning automotive ... operates over 30 locations, primarily through its franchise ...
(Date:5/24/2013)... in five parents think they have little control over ... drug use, a new U.S. government survey finds. ... and Mental Health Services Administration (SAMHSA), since new research ... influential forces helping to shape their child,s views on ... that parents can make an enormous difference in influencing ...
(Date:5/24/2013)... The SunglassFIX Photo Contest lets ... while learning how to make their sunglasses, and ... only need to upload pictures of themselves, friends ... Sunglass Fix on Facebook in order to enter. ... lens replacement online store . , ...
(Date:5/24/2013)... A new investigational device - the Helio System (TF-FA) ... Transcatheter Heart Valve was successfully deployed in all four ... use in high-risk aortic insufficiency reported at EuroPCR 2013. ... to help stabilise the SAPIEN XT valve for patients ... are captured between the transcatheter heart valve and the ...
Breaking Medicine News(10 mins):Health News:The Dictation Source Signs Two National Hospital Chains 2Health News:The Dictation Source Signs Two National Hospital Chains 3Health News:Cortec Closes Equity Transaction with 101 Mobility 2Health News:Parents Underestimate Influence Over Teens' Substance Abuse: Survey 2Health News:Break the Sunglass Mold – Reuse 'Em, Don’t Toss 'Em then Enter the SunglassFIX Photo Contest to Win 2Health News:Feasibility trial reports deployment of new device for TAVI in aortic insufficiency 2
... UNION CITY, Calif., Sept. 2 Abaxis, Inc.,(Nasdaq: ... point-of-care,blood analysis systems, announced today that Clint Severson, ... CEO Conference "Best Under,a Billion" panel on Tuesday, ... About Abaxis, Abaxis develops, manufactures and ...
... Sept. 2 /PRNewswire/ - U.S. Preventive Medicine, Inc.,( ... the appointment of Ron Loeppke, M.D., MPH, as ... is focused on researching,the role of primary, secondary ... intervention) in improving health and,productivity in the workplace, ...
... Man with Cerebral Palsy to Enjoy Time,with Wife and New ... were,the happy words marking the arrival of little Christopher Sokol. ... at the birth of,their first child, but they anticipated challenges ... became a lot easier for,them, thanks to a donated power ...
... policymakers, leaders and health experts have adopted a global plan ... , The plan, contained in the World Cancer Declaration, recommends ... priority steps that need to be taken in order to ... of the World Cancer Congress in Geneva and offered as ...
... high risk of developing cardiovascular disease (CVD) over the next 10 ... in the September issue of IJCP, the International Journal of ... at high risk is greatest when it comes to middle-aged men, ... was carried out by Oxford University and funded by Unilever. ...
... the largest multi-institutional study to date examining the impact ... of individuals with suspected recurrent colorectal cancer, researchers found ... of patients, according to an article in the September ... , The study was conducted at four sites throughout ...
Cached Medicine News:Health News:U.S. Preventive Medicine Appoints Ron Loeppke, M.D. as Co-Chairman of Its National Advisory Board 2Health News:U.S. Preventive Medicine Appoints Ron Loeppke, M.D. as Co-Chairman of Its National Advisory Board 3Health News:The SCOOTER Store Donates Power Wheelchair, Giving New Parents Chance to Be an Active Family 2Health News:World Cancer Declaration sets ambitious targets for 2020 2Health News:Millions face undiagnosed heart risk say researchers after mass screening 2Health News:Millions face undiagnosed heart risk say researchers after mass screening 3Health News:PET scans lead to treatment changes in majority of colorectal cancer patients 2
Shandon Paraffin Block Cartons...
The Modular Storage Drawers provide permanent storage and identification of up to 165 embedding rings or 250 cassettes per drawer....
Cardboard Block Filing Cabinet is an economical solution for block storage needs....
Shandon Carousel Cassette MicroWriter™ is a carousel-type cassette marking system....
Medicine Products: